Effects of Excipients on the Chemical and Physical Stability of Glucagon during Freeze-Drying and Storage in Dried Formulations

[1]  Kenneth E. Avis,et al.  Biotechnology and Biopharmaceutical Manufacturing, Processing, and Preservation , 2020 .

[2]  Theodore W Randolph,et al.  Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin. , 2010, Journal of pharmaceutical sciences.

[3]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[4]  D. Hambly,et al.  The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studies. , 2009, Journal of pharmaceutical sciences.

[5]  Susanne Hostrup,et al.  Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients , 2009, Expert opinion on drug delivery.

[6]  Tomi Järvinen,et al.  The stability and dissolution properties of solid glucagon/gamma-cyclodextrin powder. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  B. Kerwin.  Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[8]  S. Auriola,et al.  The effect of cyclodextrins on chemical and physical stability of glucagon and characterization of glucagon/gamma-CD inclusion complexes. , 2008, Journal of pharmaceutical sciences.

[9]  Michael J. Pikal,et al.  Protein Stability During Freezing: Separation of Stresses and Mechanisms of Protein Stabilization , 2007, Pharmaceutical development and technology.

[10]  S. Yoshioka,et al.  β-Relaxation of Insulin Molecule in Lyophilized Formulations Containing Trehalose or Dextran as a Determinant of Chemical Reactivity , 2006, Pharmaceutical Research.

[11]  M. Sawai,et al.  Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon. , 2005, Journal of pharmaceutical sciences.

[12]  B. Chauhan,et al.  Cyclodextrins: application in different routes of drug administration. , 2005, Acta pharmaceutica.

[13]  S. Onoue,et al.  Mishandling of the Therapeutic Peptide Glucagon Generates Cytotoxic Amyloidogenic Fibrils , 2004, Pharmaceutical Research.

[14]  N. Warne,et al.  Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures. , 2004, Journal of pharmaceutical sciences.

[15]  Theodore W Randolph,et al.  Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma. , 2003, Journal of pharmaceutical sciences.

[16]  L. Kirsch,et al.  The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions. , 2002, Journal of pharmaceutical sciences.

[17]  L. Kirsch,et al.  The degradation pathways of glucagon in acidic solutions. , 2000, International journal of pharmaceutics.

[18]  Y. Wang,et al.  The formation and mechanism of multimerization in a freeze-dried peptide. , 2000, International journal of pharmaceutics.

[19]  C. Schebor,et al.  Stability to hydrolysis and browning of trehalose, sucrose and raffinose in low-moisture systems in relation to their use as protectants of dry biomaterials , 1999 .

[20]  E. Topp,et al.  Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.

[21]  S. Frokjaer,et al.  Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. , 1998, Archives of biochemistry and biophysics.

[22]  M. Manning,et al.  Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.

[23]  Michael J. Pikal,et al.  Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.

[24]  B. D. Anderson,et al.  Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation. , 1997, Journal of pharmaceutical sciences.

[25]  B. D. Anderson,et al.  Solid-State Stability of Human Insulin I. Mechanism and the Effect of Water on the Kinetics of Degradation in Lyophiles from pH 2–5 Solutions , 1996, Pharmaceutical Research.

[26]  D. Granner,et al.  The genes of hepatic glucose metabolism. , 1990, The Journal of biological chemistry.

[27]  W. Caughey,et al.  Protein secondary structures in water from second-derivative amide I infrared spectra. , 1990, Biochemistry.

[28]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[29]  A. D. Osborne,et al.  Secondary structure and dynamics of glucagon in solution. , 1982, Biochimica et biophysica acta.

[30]  K. Flanders,et al.  [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization. , 1982, Biochemistry.

[31]  Nooijen Wj,et al.  Immunogenicity and Bioactivity of Glucagon, Modified at Methionine-27 , 1979 .

[32]  W. Gratzer,et al.  Conformational nature of monomeric glucagon. , 1974, European journal of biochemistry.

[33]  J. M. Creeth,et al.  Presence ot trimers in glucagon solution. , 1972, European journal of biochemistry.

[34]  W. Gratzer,et al.  Relation between conformation and association state. A study of the association equilibrium of glucagon. , 1969, The Journal of biological chemistry.

[35]  W. Gratzer,et al.  Formation and structure of gels and fibrils from glucagon. , 1969, European journal of biochemistry.

[36]  A. Puigserver,et al.  Kinetics of hydrolysis of fructooligosaccharides in mineral-buffered aqueous solutions: influence of pH and temperature. , 2003, Journal of agricultural and food chemistry.

[37]  Theodore W Randolph,et al.  Surfactant-protein interactions. , 2002, Pharmaceutical biotechnology.

[38]  W. Caughey,et al.  Infrared methods for study of hemoglobin reactions and structures. , 1994, Methods in enzymology.

[39]  H. Kempen,et al.  Immunogenicity and bioactivity of glucagon, modified at methionine-27. , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.